# Long-term Prognosis of Patients With Sepsis After Immunotherapy

> **NCT04901104** · — · NOT_YET_RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 900 (estimated)

## Conditions studied

- Long-term Effects of Thymosin Alpha 1 Treatment

## Interventions

- **DRUG:** Thymosin Alpha1

## Key facts

- **NCT ID:** NCT04901104
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2021-07-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2021-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04901104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04901104, "Long-term Prognosis of Patients With Sepsis After Immunotherapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04901104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*